From Seattletimes · · 1m
HIV Drug Access Crisis in Uganda
Uganda's sex workers and HIV patients face shortages of promising lenacapavir shots despite FDA approval of affordable generic versions.
In brief
Uganda's sex workers and HIV patients face shortages of promising lenacapavir shots despite FDA approval of affordable generic versions. Uganda's HIV prevention drug lenacapavir shortages persist despite FDA approving a $40 annual generic version for low-income countries. Originally reported by Seattletimes.
Sex worker in Mbarara
Lisa Mutoni uses condoms to protect against HIV but faces condom removal during sex.
“They tell me that it is finished”
Lenacapavir promise
New drug lenacapavir offers near-complete hiv protection with two shots yearly.
Access frustration
Sex workers and patients report lenacapavir shortages despite high demand.
“They tell me that it is finished”
FDA approval
U.s. food and drug administration tentatively approved lenacapavir generic version at $40 annual cost.
Uganda's HIV rate
Mbarara city has 10% adult hiv rate double uganda's national average.
Dose shortage
Only 40 lenacapavir doses received in april were used for pregnant mothers before expanding to others.
Demand and supply gap
High demand for lenacapavir outpaces available doses in uganda's health centers.
Here's the gist
Uganda's HIV prevention drug lenacapavir shortages persist despite FDA approving a $40 annual generic version for low-income countries.
